1 ent of complement (C5aR) or interleukin-8 A (IL-8RA).

2 phosphorylation and cross-desensitization of IL-8RA.

3 orylated and cross-desensitized responses to IL-8RA.

4  main regions of sequence divergence between IL-8RA and IL-8RB (the N-terminal segment before TMD1, t

5    Functional interleuin-8 (IL-8) receptors (IL-8RA and IL-8RB: CXCR1 and CXCR2, respectively) have b

6 , GRO alpha and NAP-2 distinct from those on IL-8RA and IL-8RB; 2) IL-8, GRO alpha and NAP-2 bound to

7             Human interleukin-8 receptors A (IL-8RA) and B (IL-8RB) are seven-transmembrane domain (T

8 e (interleukin-8) receptors, CXCR1 (formally IL-8RA) and CXCR2 (formally IL-8RB), using blocking mono

9 -8 (or CXCL8) activates the receptors CXCR1 (IL-8RA) and CXCR2 (IL-8RB) to induce chemotaxis in leuko

10 e (7-TMR) G-protein coupled receptors CXCR1 (IL-8RA) and CXCR2 (IL-8RB), while GROalpha, GRObeta, GRO

11 ular context, we expressed an IL-8 receptor (IL-8RA) and FMLP receptor (FPR) in the lymphoid cell lin

12 rophil-activating peptide-2 (NAP-2), whereas IL-8RA is selective only for IL-8.

13                     However, unlike C5aR and IL-8RA, mPAFR did not inhibit the ability of FR to activ

14 s after initiation of contact and rolling of IL-8RA transfectants on VCAM-1/IL-8 co-coated surface; a

15 ated reciprocally, the N-terminal segment of IL-8RA was not a dominant selectivity determinant.

16 sistant to cross-phosphorylation by C5aR and IL-8RA, was not phosphorylated by mPAFR.